Dendreon Corporation (Nasdaq: DNDN) today announced that it has completed the submission of the amended Biologics License Application for PROVENGE® ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE